产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
BVDV-IN-1 | B646716-50mg | ≥98% | 345651-04-9 | 50mg | ¥ 8600.9 | 期货,请咨询 | 阿拉丁 |
BVDV-IN-1 | B646716-25mg | ≥98% | 345651-04-9 | 25mg | ¥ 5400.9 | 期货,请咨询 | 阿拉丁 |
BVDV-IN-1 | B646716-10mg | ≥98% | 345651-04-9 | 10mg | ¥ 2700.9 | 期货,请咨询 | 阿拉丁 |
BVDV-IN-1 | B646716-100mg | ≥98% | 345651-04-9 | 100mg | ¥ 12900.9 | 期货,请咨询 | 阿拉丁 |
Benzoyloxypaeoniflorin | B646697-5mg | ≥98% | 72896-40-3 | 5mg | ¥ 5200.9 | 期货,请咨询 | 阿拉丁 |
Benzoyloxypaeoniflorin | B646697-1mg | ≥98% | 72896-40-3 | 1mg | ¥ 1980.9 | 期货,请咨询 | 阿拉丁 |
Byakangelicol | B646694-5mg | ≥99% | 26091-79-2 | 5mg | ¥ 1980.9 | 期货,请咨询 | 阿拉丁 |
Byakangelicol | B646694-20mg | ≥99% | 26091-79-2 | 20mg | ¥ 5710.9 | 期货,请咨询 | 阿拉丁 |
Byakangelicol | B646694-10mg | ≥99% | 26091-79-2 | 10mg | ¥ 3360.9 | 期货,请咨询 | 阿拉丁 |
Bevenopran | B646620-5mg | ≥98% | 676500-67-7 | 5mg | ¥ 3799.9 | 现货 | 阿拉丁 |
Bevenopran | B646620-25mg | ≥98% | 676500-67-7 | 25mg | ¥ 8499.9 | 现货 | 阿拉丁 |
Bevenopran | B646620-1mg | ≥98% | 676500-67-7 | 1mg | ¥ 1599.9 | 现货 | 阿拉丁 |
Bevenopran | B646620-10mg | ≥98% | 676500-67-7 | 10mg | ¥ 5499.9 | 现货 | 阿拉丁 |
Befiradol | B646611-5mg | ≥95% | 208110-64-9 | 5mg | ¥ 1000.9 | 期货,请咨询 | 阿拉丁 |
Befiradol | B646611-50mg | ≥95% | 208110-64-9 | 50mg | ¥ 6100.9 | 期货,请咨询 | 阿拉丁 |
Befiradol | B646611-25mg | ≥95% | 208110-64-9 | 25mg | ¥ 3800.9 | 期货,请咨询 | 阿拉丁 |
Befiradol | B646611-10mg | ≥95% | 208110-64-9 | 10mg | ¥ 1700.9 | 期货,请咨询 | 阿拉丁 |
BAY 2476568 | B646604-5mg | ≥98% | 2311901-93-4 | 5mg | ¥ 6800.9 | 期货,请咨询 | 阿拉丁 |
BAY 2476568 | B646604-10mg | ≥98% | 2311901-93-4 | 10mg | ¥ 10900.9 | 期货,请咨询 | 阿拉丁 |
Bi-Mc-VC-PAB-MMAE | B646595-5mg | ≥99% | 1620837-70-8 | 5mg | ¥ 11250.9 | 期货,请咨询 | 阿拉丁 |
Bi-Mc-VC-PAB-MMAE | B646595-1mg | ≥99% | 1620837-70-8 | 1mg | ¥ 4500.9 | 期货,请咨询 | 阿拉丁 |
BIZ 114 | B646530-50mg | ≥98% | 2099120-74-6 | 50mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
BIZ 114 | B646530-10mg | ≥98% | 2099120-74-6 | 10mg | ¥ 2050.9 | 期货,请咨询 | 阿拉丁 |
BIZ 114 | B646530-100mg | ≥98% | 2099120-74-6 | 100mg | ¥ 9500.9 | 期货,请咨询 | 阿拉丁 |